ZNHIT1 Human

Zinc Finger HIT-Type Containing 1 Human Recombinant
Cat. No.
BT28684
Source
Escherichia Coli.
Synonyms
Zinc Finger HIT-Type Containing 1, ZNHIT1, ZNFN4A1, Zinc Finger Protein, Subfamily 4A (HIT Domain Containing) Member 1, Zinc Finger HIT Domain Containing 1, Putative Cyclin G1 Interacting Protein, Cyclin-G1-Binding Protein 1, Zinc Finger Protein Subfamily 4A Member 1, P18 Hamlet, CG1I, H_DJ0747G18.14, p18Hamlet, Zinc Finger HIT Domain-Containing Protein 1, Zinc Finger HIT Type 1, CGBP1.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

ZNHIT1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 177 amino acids (1-154) and having a molecular mass of 19.9kDa. ZNHIT1 is fused to a 23 amino acid His-tag at N-terminus.

Product Specs

Introduction
Zinc Finger HIT-Type Containing 1 (ZNHIT1), a member of the ZNHIT1 family, possesses a single HIT-type zinc finger. This protein, induced by DNA damage, appears to play a role in p53-mediated apoptosis induction. ZNHIT1 interacts with MAPK11 and MAPK14 and is a component of the chromatin-remodeling SRCAP complex, which consists of at least SRCAP, DMAP1, RUVBL1, RUVBL2, ACTL6A, YEATS4, ACTR6, and ZNHIT1. Additionally, ZNHIT1 binds to NR1D2, negating its inhibitory effect on APOC3 transcription without affecting its DNA-binding activity.
Description
Recombinant human ZNHIT1, produced in E. coli, is a single, non-glycosylated polypeptide chain composed of 177 amino acids (residues 1-154). It has a molecular weight of 19.9 kDa and includes a 23 amino acid His-tag at the N-terminus.
Physical Appearance
The product is a sterile, colorless solution.
Formulation
The ZNHIT1 solution is provided at a concentration of 1 mg/ml in a buffer containing 20 mM Tris-HCl (pH 8.0), 10% glycerol, and 0.4 M Urea.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure optimal stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is advised. Avoid repeated freeze-thaw cycles.
Purity
The purity of the product is greater than 95.0% as determined by SDS-PAGE analysis.
Synonyms
Zinc Finger HIT-Type Containing 1, ZNHIT1, ZNFN4A1, Zinc Finger Protein, Subfamily 4A (HIT Domain Containing) Member 1, Zinc Finger HIT Domain Containing 1, Putative Cyclin G1 Interacting Protein, Cyclin-G1-Binding Protein 1, Zinc Finger Protein Subfamily 4A Member 1, P18 Hamlet, CG1I, H_DJ0747G18.14, p18Hamlet, Zinc Finger HIT Domain-Containing Protein 1, Zinc Finger HIT Type 1, CGBP1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMVEKKTS VRSQDPGQRR VLDRAARQRR INRQLEALEN DNFQDDPHAG LPQLGKRLPQ FDDDADTGKK KKKTRGDHFK LRFRKNFQAL LEEQNLSVAE GPNYLTACAG PPSRPQRPFC AVCGFPSPYT CVSCGARYCT VRCLGTHQET RCLKWTV.

Product Science Overview

Introduction

Zinc Finger HIT-Type Containing 1 (ZNHIT1) is a protein encoded by the ZNHIT1 gene in humans. This protein is part of the zinc finger protein family, which is characterized by the presence of zinc finger domains that facilitate binding to DNA, RNA, or other proteins. The HIT (Histidine Triad) domain is a specific type of zinc finger domain that plays a crucial role in various cellular processes.

Gene and Protein Structure

The ZNHIT1 gene is located on chromosome 7 and is responsible for encoding the ZNHIT1 protein. The protein itself contains a HIT domain, which is essential for its function. The HIT domain is known for its ability to bind to nucleic acids and other proteins, making it a versatile component in cellular mechanisms.

Function

ZNHIT1 plays a significant role in chromatin remodeling, a process that alters the structure of chromatin to regulate gene expression. It promotes the incorporation of the histone variant H2AZ1 into the genome, which is crucial for regulating gene expression . This incorporation is mediated by the SRCAP complex, which ZNHIT1 helps to recruit to specific genomic sites.

Additionally, ZNHIT1 is involved in maintaining hematopoietic stem cell (HSC) quiescence by determining chromatin accessibility at distal enhancers of HSC quiescence genes such as PTEN, FSTL1, and KLF4 . This regulation ensures the sustained transcription of these genes and restricts PI3K-AKT signaling inhibition.

Clinical Significance

Mutations or dysregulation of the ZNHIT1 gene have been associated with certain diseases. For instance, ZNHIT1 has been linked to Spastic Paraplegia 27, an autosomal recessive disorder characterized by progressive weakness and spasticity of the lower limbs . Understanding the function and regulation of ZNHIT1 can provide insights into the mechanisms underlying such diseases and potentially lead to therapeutic interventions.

Recombinant ZNHIT1

Recombinant ZNHIT1 is a form of the protein that is produced through recombinant DNA technology. This involves inserting the ZNHIT1 gene into an expression system, such as bacteria or yeast, to produce the protein in large quantities. Recombinant ZNHIT1 is used in various research applications to study its function and interactions with other molecules.

The recombinant protein is typically purified and supplied in a solution containing buffers and stabilizers to maintain its activity. For example, a common preparation of recombinant ZNHIT1 includes 20mM Tris-HCl buffer (pH 8.0), 10% glycerol, and 0.4M urea .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.